Fundz

Carmat Gets Blended Funding Of Up To €17.5M As A Winner Of The European Innovation Council (Eic) Accelerator

PRIVATEDec 19, 2022

Round Type

Funding Round

ParisManufacturingBiotechnologyHealth CareMedical Device

Investors

European Innovation Council Fund

Description

Regulatory News:

Quick answer

CARMAT raised an undisclosed amount in a Funding Round round, dated December 19, 2022. Investors: European Innovation Council Fund. CARMAT is based in Paris, Ile-de-France, France.

How much did CARMAT raise?
CARMAT raised an undisclosed amount in a Funding Round round on December 19, 2022.
Who invested in CARMAT?
European Innovation Council Fund is named as investors in this round.
What does CARMAT do?
CARMAT is a French MedTech that designs, manufactures and markets the Aeson® artificial heart.
Where is CARMAT based and how big is it?
CARMAT is based in Paris, Ile-de-France, France.
Who are the decision-makers at CARMAT?
Fundz holds 1 contact at CARMAT, including the CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical Device and Manufacturing around the same time

Companies in the same sectors as CARMAT that raised within 45 days of this round, from Fundz verified event records.

  • MedX Health raised an undisclosed amount (Convertible Note) on January 6, 2023.
  • Evergreen Theragnostics raised $15M on December 15, 2022.
  • MedX Health raised an undisclosed amount (Convertible Note) on November 18, 2022.
  • The Shape Sensing Company raised an undisclosed amount (Funding Round) on November 10, 2022.
  • Syntach AB raised $19M (Funding Round) on January 30, 2023.
  • Julier Medical raised $3.2M (Seed) on January 23, 2023.

Who to call at CARMAT, and when

A new round usually means CARMAT is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CARMAT raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CARMAT, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CARMAT. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CARMAT

Location

Paris, Ile-de-France, France

About

CARMAT is a French MedTech that designs, manufactures and markets the Aeson® artificial heart. The Company’s ambition is to make Aeson® the first alternative to a heart transplant, and thus provide a therapeutic solution to people suffering from end-stage biventricular heart failure, who are facing a well-known shortfall in available human grafts. The world’s first physiological artificial heart that is highly hemocompatible, pulsatile and self-regulated, Aeson® could save, every year, the lives of thousands of patients waiting for a heart transplant. The device offers patients quality of life and mobility thanks to its ergonomic and portable external power supply system that is continuously connected to the implanted prosthesis. Aeson® is commercially available as a bridge to transplant in the European Union and other countries that recognize CE marking. Aeson® is also currently being assessed within the framework of an Early Feasibility Study (EFS) in the United States. Founded in 2008, CARMAT is based in the Paris region, with its head offices located in Vélizy-Villacoublay and its production site in Bois-d’Arcy. The Company can rely on the talent and expertise of a multidisciplinary team of more than 200 highly specialized people. CARMAT is listed on the Euronext Growth market in Paris (Ticker: ALCAR / ISIN code: FR0010907956).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CARMAT raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsStéphane P., CEO hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for CARMAT's next move

See what Strategic adds

CARMAT raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.